Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith M Skubitz

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Cancer Chemotherapy and Pharmacology|May 2, 2019
Development of cutaneous squamous cell carcinoma after prolonged exposure to pegylated liposomal doxorubicin and hand-foot syndrome: a newly recognized toxicityDaniel F Pease, Bruce A Peterson, Scott Gilles, et al.
Clinical & Experimental Metastasis|April 23, 2003
Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cellsRachael C Casey, Theodore R Oegema, Keith M Skubitz, et al.
Gynecologic Oncology|March 30, 2004
Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayersKathryn M Burleson, Rachael C Casey, Keith M Skubitz, et al.
Journal of Translational Medicine|June 22, 2014
Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomasKeith M Skubitz, Amy P N Skubitz, Wayne W Xu, et al.
Journal of Translational Medicine|April 20, 2019
Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcomaKeith M Skubitz, Jon D Wilson, Edward Y Cheng, et al.
Clinical & Experimental Metastasis|July 15, 2003
Establishment of an in vitro assay to measure the invasion of ovarian carcinoma cells through mesothelial cell monolayersRachael C Casey, Kimberly A Koch, Theodore R Oegema, et al.
Pharmacogenomics|July 31, 2012
Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumorsAmit K Mitra, Mark N Kirstein, Amit Khatri, et al.
Cancer Medicine|January 10, 2014
Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activityBenjamin S Misemer, Amy P N Skubitz, J Carlos Manivel, et al.
The American Journal of Pathology|July 28, 2004
Differential gene expression in ovarian carcinoma: identification of potential biomarkersKathleen Hibbs, Keith M Skubitz, Stefan E Pambuccian, et al.
Cancer|August 24, 2017
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcomaBrian L Samuels, Sant P Chawla, Neeta Somaiah, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|May 2, 2019
Development of cutaneous squamous cell carcinoma after prolonged exposure to pegylated liposomal doxorubicin and hand-foot syndrome: a newly recognized toxicityDaniel F Pease, Bruce A Peterson, Scott Gilles, et al.
Clinical & Experimental Metastasis|April 23, 2003
Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cellsRachael C Casey, Theodore R Oegema, Keith M Skubitz, et al.
Gynecologic Oncology|March 30, 2004
Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayersKathryn M Burleson, Rachael C Casey, Keith M Skubitz, et al.
Journal of Translational Medicine|June 22, 2014
Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomasKeith M Skubitz, Amy P N Skubitz, Wayne W Xu, et al.
Journal of Translational Medicine|April 20, 2019
Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcomaKeith M Skubitz, Jon D Wilson, Edward Y Cheng, et al.
Clinical & Experimental Metastasis|July 15, 2003
Establishment of an in vitro assay to measure the invasion of ovarian carcinoma cells through mesothelial cell monolayersRachael C Casey, Kimberly A Koch, Theodore R Oegema, et al.
Pharmacogenomics|July 31, 2012
Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumorsAmit K Mitra, Mark N Kirstein, Amit Khatri, et al.
Cancer Medicine|January 10, 2014
Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activityBenjamin S Misemer, Amy P N Skubitz, J Carlos Manivel, et al.
The American Journal of Pathology|July 28, 2004
Differential gene expression in ovarian carcinoma: identification of potential biomarkersKathleen Hibbs, Keith M Skubitz, Stefan E Pambuccian, et al.
Cancer|August 24, 2017
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcomaBrian L Samuels, Sant P Chawla, Neeta Somaiah, et al.
Pageof 7